Oral NMN and NR supplements have very low bioavailability — roughly 1 to 5% of an oral dose actually reaches your cells as usable NAD+, because the molecule has to survive stomach acid, first-pass liver metabolism, and limited cellular transporters. NAD+ IV therapy bypasses every one of those barriers. The infusion delivers therapeutic doses directly into your bloodstream, which is why patients describe IV NAD+ as something they actually feel within two or three sessions, while a bottle of capsules often produces no noticeable effect after months. At InfusaLounge in Allen, TX, NAD+ IV infusions are administered by Triny Nguyen, APRN under medical oversight from Phyllis J. Gee, MD, FACOG, with doses ranging from 150mg to 1000mg.
You’ve seen the ads. NMN capsules promising to turn back the clock. NAD+ patches you stick on your arm before bed. Sublingual sprays, lozenges, longevity stacks with premium price tags. And maybe, like many of the patients who eventually walk into our Allen clinic, you spent six months trying one of them and felt nothing.
There’s a reason for that, and it isn’t that NAD+ doesn’t work. It’s that a capsule cannot deliver NAD+ to your cells in any meaningful quantity. The molecule is too fragile and your gut is too inefficient. Here’s what’s actually happening, what the alternative looks like, and what NAD+ can do when it’s delivered in a form your body can use.
What NAD+ Actually Does
NAD+ — nicotinamide adenine dinucleotide, if you want the full name — is a coenzyme present in every cell in your body. It’s essential for converting food into cellular energy. Without enough NAD+, your cells cannot produce ATP efficiently, repair damaged DNA, or activate the longevity pathways that keep you biologically young.
The problem is that NAD+ levels don’t stay constant. By age 50, your levels have typically dropped by half compared to your 20s. According to a 2020 review published in Frontiers in Aging Neuroscience, declining NAD+ is implicated in many age-related conditions including cognitive decline, metabolic dysfunction, and reduced cellular repair capacity.
You feel that decline as fatigue, brain fog, slow recovery, hormonal flatness, and the vague sense that you’re running on three cylinders instead of four. Restoring NAD+ doesn’t just relieve those symptoms. It restores the engine that prevents the symptoms in the first place.
Why Oral NMN Doesn’t Work the Way You’d Expect
NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are NAD+ precursors. Your body has to convert them into NAD+ through a multi-step metabolic process, and at each step you lose product. In practice, the conversion is brutal.
Oral NMN has to make it past your stomach acid, which degrades a significant portion before it ever reaches the intestine. Then it faces first-pass liver metabolism, where most of what survives the stomach gets processed and excreted. What’s left has to navigate cellular uptake, which requires specific transporters that are themselves limited in capacity.
Published pharmacokinetic research confirms this. A 2021 study in Nature Communications on NMN demonstrated that oral NMN’s contribution to cellular NAD+ levels is significantly limited by these absorption barriers.
Of a typical bottle of oral NMN, only a small fraction actually makes it to your cells as usable NAD+. The rest is in your urine. That’s not a knock on the chemistry of NMN. It’s a knock on the delivery method.
How IV NAD+ Solves the Bioavailability Problem
The IV solves all of this in one step. When NAD+ is delivered intravenously, the molecule enters your bloodstream directly at therapeutic doses your gut could never deliver. It bypasses stomach acid, liver metabolism, and intestinal absorption limits, circulating to your cells in a form they can immediately use.
That’s why our patients describe IV NAD+ as a felt experience: clearer thinking by the second infusion, sustained energy by the third, better sleep, faster recovery, and that hard-to-describe sense of being back online that capsules don’t produce.
Bioavailability isn’t a marketing argument. It’s the entire story.
What an NAD+ IV Looks Like at InfusaLounge
At InfusaLounge in Allen, an NAD+ IV is a slow, comfortable infusion in our lounge — not a chair in a hallway, not a clinical procedure room. You arrive, get settled in a recliner, and your nurse starts the drip. Some patients read. Some watch a show on a tablet. Many fall asleep.
We offer five infusion dose tiers, calibrated to where you are and what you’re trying to accomplish:
- 150mg — Entry dose for first-timers and ongoing maintenance (60 to 90 minutes)
- 250mg — Standard dose for most patients (90 to 120 minutes)
- 500mg — Enhanced dose for sustained restoration (2 to 3 hours)
- 750mg — Advanced dose for chronic conditions (3 to 4 hours)
- 1000mg — Maximum dose for severe fatigue, post-viral recovery, and intensive longevity protocols (4 to 5 hours)
For patients who want maintenance support between infusions, we also offer faster alternatives: NAD+ 50mg or 100mg IM injections (3 to 5 minutes), at-home subQ injection kits, and a NAD+ nasal spray for cognitive support on the go.
The dose you start at depends on your goals, your medical history, and your tolerance. Triny will walk you through the right choice during your consultation.
What Patients Actually Feel During the Infusion
There’s one thing every new NAD+ patient should know before their first infusion. The first 20 minutes can be uncomfortable. Some patients feel warmth, mild chest pressure, or flushing. It’s not dangerous — NAD+ is what clinicians call vasoactive, meaning it changes blood flow in a way some patients feel acutely — but it can be surprising if you weren’t expecting it.
We solve this by slowing the drip the moment you feel anything. Within a few minutes, the sensation fades. You go back to your book, your show, your nap.
The benefits come afterward. Most patients describe feeling sharper, calmer, and lighter for several days after their first infusion. By the third or fourth, the benefits compound, and the sensation of running on full becomes the new baseline rather than an occasional surprise.
When NAD+ IV Therapy Makes the Most Sense
NAD+ IV therapy is particularly effective for chronic fatigue, brain fog, post-viral recovery, and longevity protocols. The therapeutic mechanism — restoring depleted cellular NAD+ levels — addresses the root metabolic dysfunction underlying many of these symptoms.
NAD+ IV therapy is a strong fit if you’re dealing with chronic fatigue or burnout that hasn’t responded to rest, sleep, or supplements; if you have brain fog and impaired focus, particularly in your 40s and beyond; if you’re recovering from a viral illness with persistent fatigue (the CDC’s long COVID research documents persistent fatigue in roughly 30% of cases); if you’re stuck in stubborn recovery from training, illness, or extended stress; if your labs look fine but you feel hormonally flat; if you have an active interest in longevity and biological-age optimization; if you’re going through medical weight loss on a GLP-1 protocol and want metabolic recovery support; or if you’re in substance-use recovery and your clinician has discussed NAD+ as part of your plan.
The combination of NAD+ with glutathione, vitamin C, and methylated B vitamins, which we often pair into a single infusion, is particularly popular with executives, athletes, and patients running high-performance protocols.
Should You Take Oral NMN At All?
After everything in this article about bioavailability, this question always comes up. Should you just throw out the bottle? Not necessarily. Once you’ve done a series of IV infusions and elevated your baseline NAD+ levels, an oral NMN supplement can help you maintain those levels between treatments.
The biology that limits oral bioavailability is the same biology that makes it useful for maintenance: a slow, steady, low-dose trickle is appropriate when you’re sustaining, not when you’re restoring.
We carry medical-grade NMN at InfusaLounge for patients who want to add it to their stack after they’ve finished a loading series.
Frequently Asked Questions
How often should I get NAD+ IV therapy?
Most patients start with a loading series of 3 to 6 infusions over 2 to 4 weeks, then transition to monthly maintenance. Some patients prefer at-home subQ injections for maintenance rather than monthly IVs. Triny will help you build a schedule during your consultation.
What if I haven’t tried oral NMN yet — should I start there?
You can, but most patients who do end up coming to us reporting that they didn’t feel anything. If you want to actually feel the difference, start with IV. Then add oral NMN for maintenance after you’ve completed a loading series.
Is NAD+ IV therapy safe?
Yes, when administered under licensed medical supervision using pharmaceutical-grade NAD+. Triny screens every patient before starting, and Dr. Gee provides medical oversight on every protocol. The dose is personalized to your tolerance, and the drip rate is adjusted in real time if you experience any of the typical first-infusion sensations.
Can I get NAD+ therapy if I’m on tirzepatide or semaglutide?
Yes. Many of our weight loss patients use NAD+ infusions during plateaus and at the end of a protocol to support metabolic recovery. The combination is one of our most-requested GLP-1 support stacks.
How long does the effect of an NAD+ infusion last?
Most patients feel the benefits for one to four weeks after a single infusion, depending on dose and starting NAD+ status. After a loading series of 3 to 6 infusions, the elevated baseline tends to hold longer, which is why monthly or every-other-month maintenance works well for most patients.
Ready to Feel the Difference?
Stop spending your supplement budget on a bottle of capsules that may or may not be doing anything. If you want to actually experience what NAD+ can do, book an IV infusion and find out the difference bioavailability makes.
InfusaLounge Integrative & Functional Medicine
190 E Stacy Rd #1720, Allen, TX 75002
Call 972-546-4318 or book your NAD+ session
Serving Allen, McKinney, Frisco, Plano, and surrounding North Dallas communities.
About the Authors
Medically reviewed by Phyllis J. Gee, MD, FACOG. Dr. Phyllis J. Gee is Medical Director of InfusaLounge Integrative & Functional Medicine. A board-certified OB/GYN and Fellow of the American College of Obstetricians and Gynecologists, she completed her Bachelor of Science in Nutrition at Cornell University, her MD at Wayne State University School of Medicine, and her residency in Obstetrics and Gynecology at Albert Einstein College of Medicine. She is an ADAPT-trained Functional Medicine practitioner (Kresser Institute) with more than 30 years of clinical experience. Dr. Gee’s research on transcervical fibroid ablation has been published in the International Journal of Gynecology and Obstetrics, and she served as a site investigator in the FDA-reviewed SONATA Pivotal IDE clinical trial. She has been cited in The New York Times. NPI 1417953241 · Texas Medical License H1583. View full bio →
Written by Melissa Chester, BBA. Founder and Director of Operations, InfusaLounge Integrative & Functional Medicine. Healthcare operations leader who built InfusaLounge from the ground up in 2018, with direct operational oversight of every clinical program. View full bio →
